Skip to main content
. 2022 Sep 19;10(9):1564. doi: 10.3390/vaccines10091564

Figure 3.

Figure 3

(A) The vaccine’s secondary structural characteristics. (B) 3D structure validation of with Z-scores is −6.64, evaluated by Pro-SA server. (C) 3D model of structured vaccine. (D) Using the PROCHECK server, an analysis of the Ramachandran plot revealed that 80.7%, 12.7%, 3.0%, and 3.6% of the residues were found in the favored, additionally allowed, allowed, and disallowed, respectively.